5-Fluorouracil-related severe toxicity: A comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency-Reference-Cited by-同舟云学术

5-Fluorouracil-related severe toxicity: A comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency

Published:2007-05 Issue:2 Volume:249 Page:271-282
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Boisdron-Celle M.,Remaud G.,Traore S.,Poirier A.L.,Gamelin L.,Morel A.,Gamelin E.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration;Ezzeldin;Clin. Colorectal Cancer,2004

2. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a french intergroup study;de Gramont;J. Clin. Oncol.,1997

3. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial;Andre;J. Clin. Oncol.,2003

4. Dihydropyrimidine dehydrogenase: its role in 5-Fluorouracil clinical toxicity and tumor resistance;Diasio;Clin. Cancer Res.,1999

5. Population study of dihydropyrimidine dehydrogenase in cancer patients;Etienne;J. Clin. Oncol.,1994

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid determination of uracil in biological fluids at mercury thin film electrode for early detection of potential 5-fluorouracil toxicity due to dihydropyrimidine dehydrogenase deficiency;Biosensors and Bioelectronics;2024-10

2. Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD);International Journal of Molecular Sciences;2024-07-11

3. Can we identify patients carrying targeted deleterious DPYD variants with plasma uracil and dihydrouracil? A GPCO-RNPGx retrospective analysis;Clinical Chemistry and Laboratory Medicine (CCLM);2024-06-19

4. Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics;Exploration of Targeted Anti-tumor Therapy;2024-04-24

5. Electrochemical investigation of an anticancer drug 5-Fluorouracil in the presence of Theophylline using low-cost and disposable poly(GLY) modified pencil graphite electrode;Analytical Biochemistry;2024-04